Cori Gorman, PhD, MBA
November 18, 2020
Trastuzumab was the first approved monoclonal antibody to target the oncogene HER2 protein… Trastuzumab was the first approved monoclonal antibody to target the oncogene HER2 protein, and its development was a life-changing therapy for women with HER2+ breast cancer. The significance of the role trastuzumab has played in treatment of breast cancer was recognized in […]